- Home
- PUMP vs CERT Comparison
PUMP vs CERT Comparison
Compare PUMP & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PUMP | CERT |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Retail: Computer Software & Peripheral Equipment |
| Sector | Energy | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PUMP | CERT |
|---|---|---|
| Price | $10.97 | $9.18 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $9.57 | ★ $14.50 |
| AVG Volume (30 Days) | ★ 2.5M | 2.1M |
| Earning Date | 10-29-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $1,300,037,000.00 | $415,551,000.00 |
| Revenue This Year | N/A | $10.82 |
| Revenue Next Year | $1.59 | $6.77 |
| P/E Ratio | ★ N/A | $135.57 |
| Revenue Growth | N/A | ★ 11.47 |
| 52 Week Low | $4.51 | $8.03 |
| 52 Week High | $11.66 | $15.69 |
Technical Indicators
Market Signals| Indicator | PUMP | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 66.62 | 45.53 |
| Support Level | $10.57 | $8.75 |
| Resistance Level | $11.27 | $9.72 |
| Average True Range (ATR) | 0.55 | 0.39 |
| MACD | 0.02 | 0.18 |
| Stochastic Oscillator | 86.82 | 71.39 |
Price Performance
Historical ComparisonAbout PUMP ProPetro Holding Corp.
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.